Prezista 75/150Mg 75mg. 150mg Tablet
PDF Leaflet Revision Date: 20 June 2013
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in antiretroviral treatment-experienced patients.
Dosage (summary)
600 mg PREZISTA with 100 mg ritonavir twice daily with food.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Key Drug Interactions
- CYP3A inhibitors
- Rifampicin
- St. John's Wort
Contraindications
- Hypersensitivity to darunavir
- Children < 3 years
- Severe hepatic impairment
Common side effects
- Diarrhoea
- Headache
- Nausea
- Fatigue
- Rash
Counselling Points
- Take with food and ritonavir
- Do not alter dosage without consulting
- Monitor for skin reactions
Serious warnings
- Severe skin reactions
- Hepatotoxicity
- Diabetes mellitus
Important Disclaimer
The Prezista 75/150Mg 75mg. 150mg Tablet professional information leaflet below is the property of Aspen Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
